# Oruka Therapeutics, Inc.: Form S-1, filed Nov 14, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: S-1
- Filed: 2024-11-14
- Accepted by EDGAR: Nov 14, 2024, 06:37 ET
- Period: not reported
- Accession: 0001213900-24-097737
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390024097737/ea0220567-s1_orukatherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390024097737/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390024097737/ea0220567-s1_orukatherap.htm

Filed Nov 14, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-097737. Last ingested by Listed: Nov 15, 2026, 02:43 ET. No prices; not investment advice.
